Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2025 | Axon Therapies | $32.0M Series A | Earlybird Venture Capital, James Eadie | EQT Life Sciences, Seroba Life Sciences, Andrew ElBardissi, Deerfield Management |
| Oct 17, 2022 | Eyenuk | $26.0M Series A | AXA IM Alts | A&C Foelsgaard Alternativer, Kendall Capital Partners, Marie-Louise Little |